Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUT014 in EGFRI Induced Acneiform Lesions
NCT04759664Phase 2Recruiting
- Sponsor
- Lutris Pharma
- Start
- Apr 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of LUT014 in acneiform rash, sponsored by Lutris Pharma. Started Apr 2021; status: recruiting.
02
Drugs
LUT014
03
Conditions
acneiform rash
Beyond the preview
Go deeper on NCT04759664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04759664.